Human melanoma: Development and progression

CANCER AND METASTASIS REVIEW

Volumn 9, Issue 2, 1990, Pages 101-112

  Herlyn, Meenhard ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

growth factors; melanoma; monoclonal antibodies; progression

Indexed keywords

GROWTH FACTOR;

CHROMOSOME ABERRATION; HUMAN; MELANOCYTE; MELANOMA; NONHUMAN; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH;

ANIMAL; HUMAN; MELANOMA; MELANOMA, EXPERIMENTAL; MICE; MICE, NUDE; NEOPLASM METASTASIS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025102645     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/BF00046337     Document Type: Article

References (31)

1. Clonal separation of mature melanocytes from premelanocytes in a diploid human cell strain: Spontaneous and induced pigmentation of premelanocytes
2. Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets
3. Regulation of growth and phenotype of normal human melanocytes in culture
4. A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma
5. The biologic forms of malignant melanoma
6. Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome
7. Invasive malignant melanomas lacking competence for metastasis
8. A model predicting survival in stage I melanoma based upon tumor progression
9. Growth and phenotypic characteristics of human nevus cells in culture
10. Biology of tumor progression in human melanocytes
11. Growth regulatory factors for normal, premalignant, and malignant human cells
12. Tumor progression in the human melanocytic system
13. Primary melanoma cells of the vertical growth phase: Similarities to metastatic cells
14. Karyotypic evolution in human malignant melanoma
15. Cytogenetics of human malignant melanoma and premalignant lesions
16. Melanoma antigens: Immunological and biological characterization and clinical significance
17. Molecular biology of tumor antigens
18. Tumor progression in human malignant melanoma: Five stages defined by their antigenic phenotypes
19. Pigmented lesion-associated antigens distinguish between benign and malignant melanocytic lesions
20. Cell surface antigens of human melanocytes and melanoma: Expression of adenosine deaminase binding protein is extinguished with melanocyte transformation
21. Expression of melanoma-associated antigens in rapidly dividing human melanocytes in culture
22. Regulatory factors that determine growth and phenotype of normal human melanocytes
23. Metastatic but not primary melanoma cell lines grow in vitro independently of exogenous growth factors
24. bFGF as an autocrine growth factor for human melanomas
25. Proliferation of human malignant melanomas is inhibited by antisense oligodeoxy-nucleotides targeted against basic fibroblast growth factor
26. Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to beta-thromboglobulin
27. Transformation of normal human melanocytes and non-malignant nevus cells by adenovirus 12-SV40 hybrid virus
28. SV40-transfected human melanocyte sensitivity to growth inhibition by the phorbolester 12-O-tetradecanoyl-phorbol-13-acetate
29. Inhibition of metastasis of a human melanoma xenograft by monoclonal antibody to the GD2/GD3 gangliosides
30. In vitro properties of human melanoma cells metastatic in nude mice